Drug Shortage Report for POTASSIUM CHLORIDE INJECTION
Report ID | 94470 |
Drug Identification Number | 02241677 |
Brand name | POTASSIUM CHLORIDE INJECTION |
Common or Proper name | POTASSIUM CHLORIDE INJECTION |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | POTASSIUM CHLORIDE |
Strength(s) | 14.9MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS |
Packaging size | 100 mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-09-20 |
Actual start date | 2019-09-20 |
Estimated end date | 2019-10-31 |
Actual end date | 2019-10-31 |
Shortage status | Resolved |
Updated date | 2019-11-01 |
Company comments | JB0821P 10 mmol Potassium Chloride in 50 mL Sterile Water for Injection (DIN: 02241677) and JB0822P 20 mmol Potassium Chloride in 50 mL Sterile Water for Injection are available as an alternative (DIN: 02241679) . For questions or concerns contact Baxter customer care (1.888.719.9955) or your local representative. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2019-11-01 | English | Compare |
v7 | 2019-10-30 | French | Compare |
v6 | 2019-10-30 | English | Compare |
v5 | 2019-10-17 | French | Compare |
v4 | 2019-10-17 | English | Compare |
v3 | 2019-09-21 | English | Compare |
v2 | 2019-09-20 | French | Compare |
v1 | 2019-09-20 | English | Compare |
Showing 1 to 8 of 8